Santen Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Santen Pharmaceutical Company Limited with three other
companies in this sector in Japan:
Ono Pharmaceutical Co Ltd
sales of 244.80 billion Japanese Yen [US$2.18 billion]
of which 88%
was Products & Goods),
Ohki Healthcare Holdings Co Ltd
(222.34 billion Japanese Yen [US$1.98 billion]
Nichi-Iko Pharmaceutical Company Limited
(163.37 billion Japanese Yen [US$1.46 billion]
of which 100%
was Ethical Pharmaceutical).
During the year ended March of 2017, sales at
Santen Pharmaceutical Company Limited were ¥199.10 billion (US$1.78 billion).
a very small
increase of 1.9%
versus 2016, when the company's sales were ¥195.29 billion.
This was the fifth consecutive year of sales increases at Santen Pharmaceutical Company Limited
(and since 2012, sales have increased a total of 74%).
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
12.3% in 2017, from
¥2.74 billion to ¥3.07 billion.